Toward the Clinical Application of Therapeutic Angiogenesis Against Pediatric Ischemic Retinopathy

키워드

참고문헌 (92)

1. Höckel M, "Therapeutic angiogenesis", Arch Surg, 128, pp.423~429 (1993)
2. Penn JS, "Oxygen-induced retinopathy in the rat", Basic Life Sci, 49, pp.1025~1028 (1988)
3. Simons M, "Therapeutic angiogenesis in cardiovascular disease", Nat Rev Drug Discov, 2, pp.863~871 (2003)
4. Losordo DW, "Therapeutic angiogenesis and vasculogenesis for ischemic disease : part II : cell-based therapies", Circulation, 109, pp.2692~2697 (2004)
5. Losordo DW, "Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I : angiogenic cytokines", Circulation, 109, pp.2487~2491 (2004)
6. Johnson T, "Approaches to therapeutic angiogenesis for ischemic heart disease", J Mol Med(Berl), 97, pp.141~151 (2019)
7. Hartnett ME, "Mechanisms and management of retinopathy of prematurity", N Engl J Med, 367, pp.2515~2526 (2012)
8. Palmer EA, "Incidence and early course of retinopathy of prematurity", Ophthalmology, 98, pp.1628~1640 (1991)
9. Smith LE, "Oxygen-induced retinopathy in the mouse", Invest Ophthalmol Vis Sci, 35, pp.101~111 (1994)
10. Connor KM, "Quantification of oxygen-induced retinopathy in the mouse : a model of vessel loss, vessel regrowth and pathological angiogenesis", Nat Protoc, 4, pp.1565~1573 (2009)
11. Gilmour DF, "Familial exudative vitreoretinopathy and related retinopathies", Eye(Lond), 29, pp.1~14 (2015)
12. Tauqeer Z, "Familial exudative vitreoretinopathy: pathophysiology, diagnosis, and management", Asia Pac J Ophthalmol(Phila), 7, pp.176~182 (2018)
13. Pendergast SD, "Familial exudative vitreoretinopathy. Results of surgical management", Ophthalmology, 105, pp.1015~1023 (1998)
14. Warden SM, "The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease", Semin Ophthalmol, 22, pp.211~217 (2007)
15. Ye X, "Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization", Cell, 139, pp.285~298 (2009)
16. Wang Y, "Norrin", Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity, 2012, pp.151, 1332~1344
17. Potente M, "Basic and therapeutic aspects of angiogenesis", Cell, 146, pp.873~887 (2011)
18. Chen ZY, "A mutation in the Norrie disease gene(NDP)associated with X-linked familial exudative vitreoretinopathy", Nat Genet, 5, pp.180~183 (1993)
19. Kim JH, "Mutations of the Norrie gene in Korean ROP infants", Korean J Ophthalmol, 16, pp.93~96 (2002)
20. Dickinson JL, "Mutations in the NDP gene : contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity", Clin Exp Ophthalmol, 34, pp.682~688 (2006)
21. Rathi S, "Mutation spectrum of NDP, FZD4 and TSPAN12 genes in Indian patients with retinopathy of prematurity", Br J Ophthalmol, 102, pp.276~281 (2018)
22. Tang M, "Mutation spectrum of the LRP5, NDP, and TSPAN12 genes in Chinese patients with familial exudative vitreoretinopathy", Invest Ophthalmol Vis Sci, 58, pp.5949~5957 (2017)
23. Li JK, "Spectrum of variants in 389 Chinese probands with familial exudative vitreoretinopathy", Invest Ophthalmol Vis Sci, 59, pp.5368~5381 (2018)
24. Sims KB, "GeneReviews(R)" (1993), University of Washington
25. Dong Hyun Jo, "How to Overcome Retinal Neuropathy: The Fight against Angiogenesisrelated Blindness", Archives of Pharmacal Research, 33(10), pp.1557~1565 (2010), 대한약학회
26. Gariano RF, "Retinal angiogenesis in development and disease", Nature, 438, pp.960~966 (2005)
27. Mintz-Hittner HA, "Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity", N Engl J Med, 364, pp.603~615 (2011)
28. Tagami M, "Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab", Graefes Arch Clin Exp Ophthalmol, 246, pp.1787~1789 (2008)
29. Mansour SE, "The evolving treatment of diabetic retinopathy", Clin Ophthalmol, 14, pp.653~678 (2020)
30. Hansson GK, "Inflammation, atherosclerosis, and coronary artery disease", N Engl J Med, 352, pp.1685~1695 (2005)
31. Hiatt WR, "Medical treatment of peripheral arterial disease and claudication", N Engl J Med, 344, pp.1608~1621 (2001)
32. Webster KA, "Therapeutic angiogenesis : a complex problem requiring a sophisticated approach", Cardiovasc Toxicol, 3, pp.283~298 (2003)
33. Henry TD, "Therapeutic angiogenesis", BMJ, 318, pp.1536~1539 (1999)
34. Bobek V, "Gene therapy of the ischemic lower limb--Therapeutic angiogenesis", Vascul Pharmacol, 44, pp.395~405 (2006)
35. Schumacher B, "Induction of neoangiogenesis in ischemic myocardium by human growth factors : first clinical results of a new treatment of coronary heart disease", Circulation, 97, pp.645~650 (1998)
36. Laham RJ, "Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery : results of a phase I randomized, double-blind, placebo-controlled trial", Circulation, 100, pp.1865~1871 (1999)
37. Hendel RC, "Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion : evidence for a dose-dependent effect", Circulation, 101, pp.118~121 (2000)
38. Simons M, "Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2 : double-blind, randomized, controlled clinical trial", Circulation, 105, pp.788~793 (2002)
39. Henry TD, "The VIVA trial : vascular endothelial growth factor in Ischemia for vascular angiogenesis", Circulation, 107, pp.1359~1365 (2003)
40. Giacca M, "Virus-mediated gene transfer to induce therapeutic angiogenesis : where do we stand?", Int J Nanomedicine, 2, pp.527~540 (2007)
41. Losordo DW, "Gene therapy for myocardial angiogenesis : initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia", Circulation, 98, pp.2800~2804 (1998)
42. Rosengart TK, "Angiogenesis gene therapy : phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease", Circulation, 100, pp.468~474 (1999)
43. Vale PR, "Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia", Circulation, 103, pp.2138~2143 (2001)
44. Losordo DW, "Phase 1", 2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia, 2002, pp.105, 2012~2018
45. Grines CL, "Angiogenic gene therapy(AGENT)trial in patients with stable angina pectoris", Circulation, 105, pp.1291~1297 (2002)
46. Fan Y, "Therapeutic angiogenesis for brain ischemia : a brief review", J Neuroimmune Pharmacol, 2, pp.284~289 (2007)
47. Goldberg JL, "UC blood hematopoietic stem cells and therapeutic angiogenesis", Cytotherapy, 9, pp.4~13 (2007)
48. Assmus B, "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction(TOPCARE-AMI)", Circulation, 106, pp.3009~3017 (2002)
49. Strauer BE, "Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans", Circulation, 106, pp.1913~1918 (2002)
50. Perin EC, "Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure", Circulation, 107, pp.2294~2302 (2003)
51. Tse HF, "Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation", Lancet, 361, pp.47~49 (2003)
52. Lazarous DF, "Basic fibroblast growth factor in patients with intermittent claudication : results of a phase I trial", J Am Coll Cardiol, 36, pp.1239~1244 (2000)
53. Lederman RJ, "Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication(the TRAFFIC study) : a randomised trial", Lancet, 359, pp.2053~2058 (2002)
54. Isner JM, "Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb", Lancet, 348, pp.370~374 (1996)
55. Baumgartner I, "Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia", Circulation, 97, pp.1114~1123 (1998)
56. Powell RJ, "Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia", Circulation, 118, pp.58~65 (2008)
57. Mäkinen K, "Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery : a randomized, placebo-controlled, double-blinded phase II study", Mol Ther, 6, pp.127~133 (2002)
58. Rajagopalan S, "Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease : a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication", Circulation, 108, pp.1933~1938 (2003)
59. Tateishi-Yuyama E, "Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells : a pilot study and a randomised controlled trial", Lancet, 360, pp.427~435 (2002)
60. Kastrup J, "Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis", Scand Cardiovasc J, 35, pp.291~296 (2001)
61. Post MJ, "Therapeutic angiogenesis in cardiology using protein formulations", Cardiovasc Res, 49, pp.522~531 (2001)
62. Khurana R, "Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease", Trends Cardiovasc Med, 13, pp.116~122 (2003)
63. Dor Y, "Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy", EMBO J, 21, pp.1939~1947 (2002)
64. Schwarz ER, "Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor(VEGF)in a myocardial infarction model in the rat--angiogenesis and angioma formation", J Am Coll Cardiol, 35, pp.1323~1330 (2000)
65. Syed IS, "Therapeutic angiogenesis : a biologic bypass", Cardiology, 101, pp.131~143 (2004)
66. Idris NM, "Therapeutic angiogenesis for treatment of peripheral vascular disease", Growth Factors, 22, pp.269~279 (2004)
67. Annex BH, "Growth factor-induced therapeutic angiogenesis in the heart : protein therapy", Cardiovasc Res, 65, pp.649~655 (2005)
68. Markkanen JE, "Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapy", Cardiovasc Res, 65, pp.656~664 (2005)
69. Emanueli C, "Therapeutic angiogenesis : translating experimental concepts to medically relevant goals", Vascul Pharmacol, 45, pp.334~339 (2006)
70. Mandai M, "Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration", N Engl J Med, 376, pp.1038~1046 (2017)
71. Bennett J, "Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations : a follow-on phase 1 trial", Lancet, 388, pp.661~672 (2016)
72. Sato T, "Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity", Ophthalmology, 116, pp.2165~2169 (2009)
73. Zhao M, "Expression of total vascular endothelial growth factor and the anti-angiogenic VEGF 165 b isoform in the vitreous of patients with retinopathy of prematurity", Chin Med J(Engl), 128, pp.2505~2509 (2015)
74. Yenihayat F, "Vitreous IL-8 and VEGF levels in diabetic macular edema with or without subretinal fluid", Int Ophthalmol, 39, pp.821~828 (2019)
75. Citirik M, "Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy", Ophthalmic Res, 47, pp.7~12 (2012)
76. Ohlmann A, "Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice", J Neurosci, 25, pp.1701~1710 (2005)
77. Ohlmann A, "Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice", J Neurosci, 30, pp.183~193 (2010)
78. Tokunaga CC, "Retinal vascular rescue of oxygen-induced retinopathy in mice by norrin", Invest Ophthalmol Vis Sci, 54, pp.222~229 (2013)
79. Zeilbeck LF, "Norrin mediates angiogenic properties via the induction of insulin-like growth factor-1", Exp Eye Res, 145, pp.317~326 (2016)
80. Cho CH, "Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis", Proc Natl Acad Sci U S A, 101, pp.5553~5558 (2004)
81. Lee J, "Angiopoietin-1 guides directional angiogenesis through integrin αvβ5 signaling for recovery of ischemic retinopathy", Sci Transl Med, 5, pp.203~ (2013)
82. Butler JM, "SDF-1 is both necessary and sufficient to promote proliferative retinopathy", J Clin Invest, 115, pp.86~93 (2005)
83. Chang KH, "IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development", Proc Natl Acad Sci U S A, 104, pp.10595~10600 (2007)
84. Caballero S, "Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells", Diabetes, 56, pp.960~967 (2007)
85. Medina RJ, "Outgrowth endothelial cells : characterization and their potential for reversing ischemic retinopathy", Invest Ophthalmol Vis Sci, 51, pp.5906~5913 (2010)
86. Prasain N, "Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells", Nat Biotechnol, 32, pp.1151~1157 (2014)
87. Wang D, "Effect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation", Int J Ophthalmol, 9, pp.1578~1583 (2016)
88. Li Calzi S, "Progenitor cell combination normalizes retinal vascular development in the oxygen-induced retinopathy(OIR)model", JCI Insight, 4, pp.e129224~ (2019)
89. Otani A, "Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis", Nat Med, 8, pp.1004~1010 (2002)
90. Lin Y, "Origins of circulating endothelial cells and endothelial outgrowth from blood", J Clin Invest, 105, pp.71~77 (2000)
91. O'Leary OE, "The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic", Exp Eye Res, 182, pp.144~155 (2019)
92. Nomi M, "Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering", Curr Stem Cell Res Ther, 1, pp.333~343 (2006)

관련 논문AI추천